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In the nervous system, several key steps in cellular complexity and development are reg-
ulated by non-coding RNAs (ncRNAs) and the repressor element-1 silencing transcription
factor/neuron-restrictive silencing factor (REST/NRSF). REST recruits gene regulatory com-
plexes to regulatory sequences, among them the repressor element-1/neuron-restrictive
silencer element, and mediates developmental stage-speciﬁc gene expression or repres-
sion, chromatin (re-)organization or silencing for protein-coding genes as well as for several
ncRNAslikemicroRNAs,shortinterferingRNAsorlongncRNAs.NcRNAsarefarfrombeing
just transcriptional noise and are involved in chromatin accessibility, transcription and post-
transcriptional processing, trafﬁcking, or RNA editing. REST and its cofactor CoREST are
both highly regulated through various ncRNAs. The importance of the correct regulation
within the ncRNA network, the ncRNAome, is demonstrated when it comes to a deregula-
tion of REST and/or ncRNAs associated with molecular pathophysiology underlying diverse
disorders including neurodegenerative diseases or brain tumors.
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INTRODUCTION
Bothexperimentalandcomputationalevidencesuggestthatmany
of the newly discovered non-coding transcripts and process-
ing products, such as the non-coding (ncRNA) small interfering
(siRNA)ormicroRNAs(miRNA),arefunctional.Likely,weunder-
estimate the complexity of the regulatory circuitry by assuming a
hierarchical structure of well-separated layers in transcriptional
regulation. At least a large fraction of the non-coding transcripts
themselves are functional and are far from being just transcrip-
tional noise – begging the question “What’s regulated in gene
regulation?”. Many of these transcripts show a differential expres-
sion in differentiation and disease; there is also sequence conser-
vation and many of the highly conserved elements give rise to
ncRNAs of heretofore-unknown function. It is of high impor-
tance to understand the fundamental principles in neuroscience,
viz. how cellular complexity, diversity, and development are regu-
lated.Suchunderstandinginbothhealthyanddiseasedconditions
will pave the way to target various diseases and to develop novel
drugs and therapeutics. Further,genomic and epigenomic studies
provide insights into the complex mechanisms that underlie the
aforementioned processes, including the important roles of ncR-
NAs and the repressor element-1 silencing transcription factor/
neuron-restrictive silencing factor (REST/NRSF). Looking at the
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complexity of the genome, the whole genome may be transcribed
with each nucleotide potentially serving as a multifunctional unit
within multiple interconnected genomic layers or elements (Bir-
ney et al., 2007). Individual cell types are characterized by their
unique repertoire of protein- and non-coding transcripts and a
cell’sidentityandfunctionisdeterminedbyaspeciﬁcseriesoftem-
poral and spatial extracellular cues, combinatorial transcription
factor codes, epigenetic regulatory networks, and complex chro-
matin dynamics. In this context, REST and its cofactor CoREST
playimportantrolesastheybindtogenomicregulatorysequences,
including the repressor element-1/neuron-restrictive silencer ele-
ment(RE1/NRSE).RESTandCoRESTmodulateahugevarietyof
protein-coding (Johnson et al., 2007; Otto et al., 2007) and non-
coding genes (Wu and Xie, 2006; Johnson et al., 2009), regulate
gene expression or repression as well as long-term gene silencing
(Zheng et al., 2009). Within the network regulated by REST and
CoREST, neural genes are connecting points and this network is
highly integrated with the ncRNAome that orchestrates aspects
as diverse as lineage restriction, stem cell maintenance, differen-
tiation, fate determination, or homeostasis (Mehler, 2008). Given
the involvement in these key regulatory pathways, it is not sur-
prising that the perturbation of REST and CoREST activity or the
related ncRNAs are implicated in the molecular pathophysiology
that underlies various diseases. Among these diseases are tumors
likemedullo-,glio-,orneuroblastoma(Coulson,2005;Blometal.,
2006;Westbrook et al.,2008),in addition to ischemia (Formisano
et al., 2007), epilepsy (Garriga-Canut et al., 2006; Bassuk et al.,
2008), or neurodegenerative diseases (Zuccato et al., 2007; Benn
et al.,2008; Packer et al., 2008).
REST AND CoREST IN NEURAL NETWORKS
The zinc ﬁnger protein REST binds to genomic sequences that
include canonical RE1 sequences. REST acts as a modulator for
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the assembly of diverse transcription factors. Initially thought to
repress only neuronal genes in non-neuronal cells (Schoenherr
and Anderson, 1995; Ballas et al., 2001), REST is now seen as a
key regulator in multifaceted pathways in various cell types and
as a modulator of the cellular epigenome. In addition to CoR-
EST, REST also recruits mSin3 (Grimes et al., 2000), a scaffold
for histone deacetylases (Hdac-1, -2, -4, and -5). When associ-
ated with REST, CoREST binds to Hdac-1 and -2, histone H3K4
lysine demethylase, LSD1, histone H3K9 methyltransferases, G9a
and Suv39h1, methyl-CpG binding protein 2 (Mecp2), and to a
componentof theSWI/SNFchromatinremodelingcomplex,Brg1
(Andres et al., 1999). REST also associates with a wide number
of epigenetic and regulatory cofactors that include DNA methyl-
transferases (DNMTs), chromatin remodeling enzymes, the RNA
polymerase II transcriptional Mediator subunits,Med-19 and -26
(Ding et al., 2009), the NADH-binding factor, CtBP (Garriga-
Canut et al., 2006; Guardavaccaro et al., 2008), the transcription
factor Sp3 (Kim et al., 2006), or the small C-terminal domain
phosphatase, Scp1 (Visvanathan et al., 2007)( Figure 1). There-
fore, REST acts as a platform for genomic integrity, stability, and
regulation and speciﬁes context-dependent gene repression or
activation. The complexity further increases when looking at the
various parameters that regulate the afﬁnity of the REST complex
through several parameters that include its afﬁnity for binding to
different RE1 and non-RE1 sites, alternative spliced variants of
REST (Shimojo et al., 1999; Lee et al., 2000a), or the modulation
via ncRNAs (Kuwabara et al., 2004; Visvanathan et al., 2007;
Packer et al., 2008).
The locus for REST contains several regulatory elements that
are targeted by transcriptional networks including Nanog and
Oct4 (Singh et al., 2008) or by factors like Wnt and retinoic acid
(Nishiharaetal.,2003).Theshufﬂingof RESTfromthenucleusto
the cytoplasm is controlled by huntingtin (Htt) and is controlled
by a complex of Htt, dynactin p150, and REST (Johnson et al.,
2008). Besides the effects of transcriptional regulation, a role of
REST in post-transcriptional processing has been shown for the
μ-opioid receptor (μOR) gene (Kim et al., 2008).
THE INTERPLAY OF REST AND ncRNAs
Since REST contains an RE1 sequence, it may be that REST reg-
ulates its own expression in a feedback loop. In this regard, it is
interesting that small double-stranded ncRNAs encoding the RE1
sequence (dsNRSEs) were found to interact with the REST com-
plextopromotetheexpressionofRE1-associatedgenes(Kuwabara
etal.,2005).ThisfactdemonstratesthecloselinkofRESTfunction
and ncRNA expression and is particularly relevant for the deter-
mination of cell fates in the nervous system. Initially, REST was
found to modulate genes for neuronal differentiation, homeosta-
sis and plasticity,including cytokines,neurotransmitter receptors,
ion channels, cell adhesion molecules, growth factors, and fac-
tors for axonal guidance or vesicle proteins at synapses (Chen
et al., 1998). A similar role has been demonstrated for miRNAs
and ncRNA networks in neuronal differentiation and plasticity
(Ooi and Wood,2008).
Genome-wide mapping, expression and binding proﬁles for
REST have been examined in various studies. REST targets both
FIGURE1|S c hematic diagram illustrating the major components of
ncRNA–REST/NRSF interactions in neural networks. A yet to identiﬁed
mechanism initiates the binding of BRG1 to REST/NRSF , resulting in the
exposure of the RE1/NRSE motif and the subsequent occupation of it by
REST/NRSF .The exact sequential order is unknown. With the assistance of
Sin3 and CoREST, the RE1-bound REST/NRSF complexes recruit histone
deacetylases (HDAC1/2) and CpG methylDNA binding protein (MeCP2), to
promote histone deacetylations, histone methylases (G9a), and histone
demethylases (LSD1). REST/NRSF can recruit additional histone methylases
and demethylases to target lysine residues of histones; arrows link cofactors
to their chromatin remodeling and modifying activities. Inhibition of these
histone modifying components results in an attenuation of REST/NRSF
recruitment, a decrease in H3K9me2, an increase in H3K9/K14 and H4
acetylation, an increase in H3K4me3 and a decrease in binding of MeCP2 to
methylated DNA. REST/NRSF-mediated regulation of neuronal gene
expression relies on the dissociation of the REST/NRSF repressor complex
from the RE1/NRSE site. In addition to the REST/NRSF complex at the
RE1/NRSE site, CoREST and MeCP2 complexes bind to genes on adjacent
methylated CpGs in their promoters throughout neuronal differentiation. In
neural progenitors, REST/NRSF is expressed and inhibits miR-124a
expression, allowing the persistence of non-neuronal transcripts. Upon
differentiation of the neuronal progenitors into neurons, REST/NRSF
dissociation from the miR-124a gene loci induces derepression of the gene,
resulting in the selective degradation of non-neuronal gene transcripts.Thus,
REST/NRSF links transcriptional and post-transcriptional events to ﬁne-tune
the balance of phenotype between neuronal and non-neuronal cells,
controlled by miR-124 and further non-coding transcripts (ncRNA) that act in a
network with miR-124. See text for references.
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the canonical and non-canonical RE1 sequence that contains
insertions in the canonical sequence of variable lengths (Ooi and
Wood, 2007; Otto et al., 2007). NcRNAs are believed to play
an important role in the regulation of REST binding to such
sequences. Among them are miRNAs that are cell type-speciﬁc
and are only expressed in the brain, viz. miR-9, miR-124, or miR-
128 (Ooi and Wood, 2008)( Figure 1). MiRNAs directly target
the 3-untranslated region (UTR) of target mRNAs leading to a
sequestration of mRNAs in P-bodies for storage or subsequent
degradation, respectively. P-bodies regulate RNA metabolism,
translational repression and play a critical role in the transport
of RNAs to dendrites regulating synaptic plasticity (Zeitelhofer et
al., 2008). Many functions of the complex ncRNAome are yet to
be uncovered, however, a large number of RE1 sites are present
within close proximity of nervous system enriched miRNA genes
– and the expression of those genes is regulated by REST (Wu and
Xie, 2006).
The important role of critical components of the RNAi medi-
ated gene silencing pathways has been demonstrated for factors
that are associated with RE1, such as Argonaute (Ago1, Ago3,
Ago4, Xpo5) or Dicer (Dicer1) proteins (Nishihara et al., 2003;
Rossbach, 2010). REST itself may be targeted by multiple ncR-
NAs, such as the miRNAs mir-9 or miR-124 (Wu and Xie, 2006;
Packeretal.,2008)and,consequently,theremaybeseverallayersof
regulation connected in neurodevelopment, e.g., double-negative
feedback loops for REST and ncRNAs. There are further classes
of non-coding regulators of REST, like long ncRNAs; 23% of the
REST binding sites lie within a 10-kb region of long ncRNA genes
(Shimojo et al., 1999). For instance, when looking at the DiGe-
orge syndrome, the locus of the DiGeorge syndrome-associated
ncRNA DGCR5 is a breakpoint region, which is characterized
by malformations during neurodevelopment and causes neu-
ropsychiatric diseases. REST binds to a binding site of DGCR5,
leading to transcriptional repression (Johnson et al.,2009). Mam-
malian genomes may encode huge amounts of such long ncRNAs,
many of them are poly-A tailed, highly regulated during devel-
opment, alternately spliced, and enriched in the nervous system.
In the brain and in embryonic stem cells (ESCs), long ncRNAs
exhibit cell type-speciﬁc, spatial, and temporal regulated expres-
sion proﬁles (Dinger et al., 2008a) Besides transcription, post-
transcriptional processing, RNA editing, and trafﬁcking (Mehler,
2008),ncRNAs regulate chromosomal architecture,dynamics and
plasticity by recruiting chromatin activator or repressor com-
plexes to their targets (Mattick et al., 2009). An example is the
ncRNAAir that accumulates at promoter regions where it silences
gene expression by recruiting the H3K9 methyltransferase G9a
(Nagano et al.,2008)( Figure 1).
NETWORK REGULATIONS MEDIATED BY ncRNAs
Non-coding transcripts not only include miRNA, siRNAs, and
long ncRNAs, but also small nucleolar RNAs (snoRNA) and anti-
sense RNAs (asRNAs) – but it is quite likely that further classes
of ncRNAs will emerge. Given the complex regulatory networks,
REST and CoREST may function as dynamic mediators of regu-
lation, thus regulating transcription, chromatin architecture and
responding to epigenetic signals (Gan et al., 2007). REST has
been implicated in cell- and tissue-speciﬁc epigenetics,and is,like
CoREST, crucial in neural stem cells (NSCs) and non-neuronal
cells, but also in ESCs, neuronal and glial progenitor cells, or in
terminally differentiated neurons and glia. During speciﬁc lineage
determination, silencing of genes involved in lineage speciﬁca-
tion and pluripotency takes place. Thus,REST is highly integrated
withthenetworkof transcriptioninmaintenanceof pluripotency,
viz. Oct4, Nanog, or Sox2 (Singh et al., 2008; Jorgensen et al.,
2009a). Studies suggest that REST is involved in ESC pluripo-
tency by targeting miRNAs like miR-21 (Singh et al., 2008); other
studies, however, ﬁnd conﬂicting results and show no signiﬁcant
impact of REST on the maintenance of pluripotency (Buckley
et al., 2009; Jorgensen et al., 2009a). Besides its potential role in
pluripotency, REST is implicated in the silencing of RE1 asso-
ciated genes in ESCs, among them genes important for neuronal
terminaldifferentiationorfunction.Examplesinclude,butarenot
limited to,Syt4,Syp,Stmn3,or Celsr3. However,Mash1 or Math1
are not on this list, suggesting that REST does not repress the
potentialforneurallineagecommitmentbutsilencesgenesimpor-
tant for neuronal subtype speciﬁcation in ESCs (Jorgensen et al.,
2009b). The role of REST in neurogenesis has been demonstrated
through the interaction of REST and ncRNAs encoding the RE1
sequence (dsNRSEs); here, REST acts as an activator and induces
neuronal differentiation (Kuwabara et al., 2005). REST-deﬁcient
NSCs show defective behavior in regard to migration and survival
(Sun et al., 2008).
Repressor element-1 silencing transcription factor is down-
regulated during NSC differentiation (Westbrook et al., 2008)
and regulates the nervous system speciﬁc miRNA miR-124 that
silences several non-neuronal genes; in non-neuronal cells, REST
silences miR-124 (Wu and Xie, 2006). During the maturation of
neurons, however, REST is suppressed and thus miR-124 levels
rise. Such observations implicate that REST plays a critical role
in neurodevelopment and in regional neuronal subtype and glial
lineage speciﬁcation, with CoREST mediating NSC maintenance
and maturational functions (Qureshi and Mehler, 2009).
INCREASING COMPLEXITY IN NEURAL NETWORKS
In healthy and diseased contexts, REST levels vary signiﬁcantly,
and both overexpression and downregulation of REST have been
observed in various disease phenotypes. Thus, REST can act as a
tumor suppressor and oncogene, respectively, depending on the
cellular environment (Westbrook et al., 2005; Weissman, 2008).
With respect to the ncRNAome, several altered levels of ncRNA
expression have been observed in various cancer phenotypes,
among them neuroblastoma or glioblastoma multiforme in the
nervous system (Nicoloso and Calin, 2008; Skog et al., 2008),
andsuchobservationsdemonstratehowanaberrantexpressionof
RESTandCoRESTisinvolvedinpathogenesisof severaldisorders
like cancer, neurodevelopmental, or neurodegenerative diseases.
Whenlookingattheepigenome,itisbecomingmoreandmore
evident that REST and its associated factors are critical modula-
tors during development, lineage speciﬁcation or gene regulation
in general and that all these processes depend on epigenetic sig-
nals. Here, another feedback regulation is in place since REST
not only mediates responses to epigenetic signal, but also targets
receptorexpressionorcomponentsof thesignalingcascade–with
ncRNAs being important for the execution of these regulatory
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processes. During neurodevelopment, the correct modiﬁcations
of RNAs are crucial, like RNA trafﬁcking, editing, or alternative
splicing. Such processes are regulated in a complex interplay of
REST,ncRNAs,andcofactorslikePtbp1thatisdirectlytargetedby
miR-124. While neuronal differentiation is progressing, miR-124
downregulates Ptbp1, leading to an increase in Ptbp2. Ptbp2 is
the nervous system homolog of Ptbp1, mediates neuron speciﬁc
alternative RNA splicing (Makeyev et al., 2007) and is targeted by
REST and CoREST during neural lineage speciﬁcation.
This complexity further increases when considering the fact
that REST has several isoforms with synergistic or antagonistic
effectsfortheregulatorynetworkRESTisintegratedinCoulsonet
al.(2000),Leeetal.(2000b),Shimojoetal.(1999).Protein-coding
RNA and ncRNA modiﬁcations, trafﬁcking, functional modiﬁ-
cations, cellular signaling, and epigenetic signal processing seem
to be modulated by REST, CoREST, and ncRNAs (Dinger et al.,
2008b). However,further studies are required to elucidate the full
picture of REST medicated ncRNA networks.
CONCLUDINGREMARKS–THETHERAPEUTICIMPLICATIONS
Theemergingconceptsof ncRNAsasnoveltherapeuticsanddiag-
nostics in neurological diseases bear both great potentials and
challenges. Several mutations,deletions,ampliﬁcations,and alter-
ations have been found in neurological and neurodegenerative
diseases and were shown to alter the expression levels of ncRNA
transcripts, like lncRNAs or miRNAs. A large fraction of highly
conserved regions encodes for sets of ncRNAs whose expression is
alteredduringdiseaseprogression.Besidesthemolecularandbio-
chemical studies,bioinformatics,and systems biology approaches
becomemoreandmoreimportantastoolstoidentifyassociations
and correlations between ncRNAs and gene regulatory networks
sincencRNAproﬁlesallowtheidentiﬁcationof varioussignatures
that are associated with diagnosis, prognosis, and the response
to treatment of neurological,neurodegenerative diseases,or brain
tumors. Detailed ncRNAome proﬁles are a ﬁrst step toward dis-
coveries leading to novel therapeutics since they were shown to
affect brain tumor development or progression and are impli-
cated in various diseases. Speciﬁcally addressing changes in the
ncRNAome in disease contexts with tools that focus on si-, lncR-
NAs, and miRNAs will lead to important ﬁndings with respect
tobiomarkerdiscoveryandtheidentiﬁcationof noveltherapeutic
targets.Thetargetingof thencRNAomeisbecominganimportant
therapeutic and diagnostic strategy,a concept known as theranos-
tics, and is therefore highly relevant for drug development and
personalized medicine. Examples include the restoration of the
expressionofadeﬁcientordownregulatedncRNAor,alternatively,
theinhibitionof anoverexpressedncRNAtoreverseadiseasephe-
notype.Thesilencingof oncogenicandthere-activationof tumor
suppressor miRNAs, for instance, are possible therapeutic para-
digmsthatarecurrentlybeingtestedinclinicaltrials.If successful,
such compounds represent new tools for the treatment of cancer
and other diseases. With their unique sequences and secondary
structural elements, ncRNAs comprise potential binding sites for
small molecular drugs acting either as agonists or antagonists,
respectively. Further areas of intervention with small molecules,
aptamers, peptides, or oligonucleotides are (i) the interaction of
ncRNAs with epigenetic effector molecules or (ii) with speciﬁc
RNA degradation pathways. Both therapeutic options can be used
to target aberrant gene expression; however, they require further
validation. Thus,the understanding of the basic processes of gene
regulation may lead toward innovative therapeutic strategies for
personalized treatments of various human diseases.
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